150 related articles for article (PubMed ID: 1197256)
1. Investigations on clinico-chemical correlations in uraemic polyneuritis.
Man NK; Cueuille G; Zingraff J; Drueke T; Jungers P; Sausse A; Billon JP; Funck-Brentano JL
Proc Eur Dial Transplant Assoc; 1975; 11():214-21. PubMed ID: 1197256
[No Abstract] [Full Text] [Related]
2. A defense of the middle molecule hypothesis.
Funck-Brentano JL; Cueille GF; Man NK
Kidney Int Suppl; 1978 Jun; (8):S31-5. PubMed ID: 278894
[No Abstract] [Full Text] [Related]
3. Middle molecules in uraemia.
Fürst P; Asaba M; Gordon A; Zimmerman L; Bergström J
Proc Eur Dial Transplant Assoc; 1975; 11():417-26. PubMed ID: 1105558
[No Abstract] [Full Text] [Related]
4. Effect of more porous dialysis membranes on neuropathic toxins.
Funck-Brentano JL; Man NK; Sausse A
Kidney Int Suppl; 1975 Jan; (2):52-7. PubMed ID: 1057693
[No Abstract] [Full Text] [Related]
5. [Uremic polyneuritis. Significance of determination of neural conduction velocity (NCV) and level of mean molecules (MM)].
El Matri A; Ben Dridi M; Belkahia C; Ben Abdallah T; Crevat A; Ben Maiz H; Ben Ayed H
Tunis Med; 1979; 57(6):348-51. PubMed ID: 555111
[No Abstract] [Full Text] [Related]
6. [Study of toxic activity of blood in uremia].
Shumakov VI; Gabriélian NI; Shcherbaneva OI; Dmitriev AA; Mogireva IA
Ter Arkh; 1980; 52(4):62-4. PubMed ID: 7404340
[No Abstract] [Full Text] [Related]
7. Serum middle molecules in uremia.
Buzio C; Manari A; Calderini C; Montagna G; Migone L
Artif Organs; 1981; 4 Suppl():143-50. PubMed ID: 7295081
[No Abstract] [Full Text] [Related]
8. Uremic middle molecules exist and are biologically active.
Bergström J; Fürst P; Zimmerman L
Clin Nephrol; 1979 May; 11(5):229-38. PubMed ID: 455821
[No Abstract] [Full Text] [Related]
9. Toxicity of uremia: physiopathology and clinical signs.
Bergström J
Contrib Nephrol; 1989; 71():1-9. PubMed ID: 2680257
[No Abstract] [Full Text] [Related]
10. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.
Popławski A; Myśliwiec M
Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345
[No Abstract] [Full Text] [Related]
11. A dialyzable toxic factor in uremia.
Lonergan ET; Semar M; Lange K
Trans Am Soc Artif Intern Organs; 1970; 16():269-71. PubMed ID: 4318263
[No Abstract] [Full Text] [Related]
12. The fraction b 4-2: isolation, characterization and biological activities with reference to uremic polyneuropathy.
Man NK; Cueille G; Faguer P; Boudet J; Pierrat D; Zingraff J; Sausse A; Funck-Brentano JL
Adv Exp Med Biol; 1987; 223():135-40. PubMed ID: 3447428
[No Abstract] [Full Text] [Related]
13. beta 2-Microglobulin and other low molecular weight proteins in haemodiafiltrates and in haemofiltrates.
Montali U; Pilone N; Cioni L; Ronca G
Int J Tissue React; 1984; 6(1):71-4. PubMed ID: 6370888
[TBL] [Abstract][Full Text] [Related]
14. Gel-filtration on psoriasic and uremic serum and dialysis fluid.
Lamperi S; Buoncristiani U; Carozzi S; Cozzari M; Icardi A; Trasforini D
Artif Organs; 1981; 4 Suppl():156-9. PubMed ID: 7295083
[TBL] [Abstract][Full Text] [Related]
15. The ultimate salt war? Uraemic toxins are all that count in dialysis patients.
Vanholder R
Nephrol Dial Transplant; 2012 Jan; 27(1):62-6. PubMed ID: 22287703
[No Abstract] [Full Text] [Related]
16. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
Popławski A; Myśliwiec M; Soszka J
Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
[TBL] [Abstract][Full Text] [Related]
17. Removal of high-molecular-weight toxins.
Hörl WH
Contrib Nephrol; 1992; 96():138-44. PubMed ID: 1740048
[No Abstract] [Full Text] [Related]
18. [Biochemical definition of uremia].
Ringoir S
Verh K Acad Geneeskd Belg; 1981; 43(2):105-19. PubMed ID: 7314875
[No Abstract] [Full Text] [Related]
19. Uremic toxins and the elusive middle molecules.
Schoots A; Mikkers F; Cramers C; de Smet R; Ringoir S
Nephron; 1984; 38(1):1-8. PubMed ID: 6472528
[No Abstract] [Full Text] [Related]
20. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
Trznadel K; Kidawa Z; Walasek L; Lutz W
Pol Tyg Lek; 1978 Feb; 33(7):257-9. PubMed ID: 758030
[No Abstract] [Full Text] [Related]
[Next] [New Search]
